IPO - Profile

DA32 Life Science Tech Acquisition Corp.

Finance > Banks

DALS

Summary

We are a newly organized blank check company incorporated in April 2021 as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date our efforts have been limited to organizational activities as well as activities related to this offering.

We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$10.00 20,000,000 Positive High 19.38%

Offering Team

  • Legal counsel
  • White and Case LLP
  • Auditors
  • WithumSmith+Brown, P.C

Deal Highlights

Deal Tracker

IPO Dates

Filing 27 Jul, 2021

Offer 28 Jul, 2021

Look Ahead

Lock Up Expiry Jan 28, 2022

IPO Terms

Offer Price $10.00
Offer Size 20M

Market Sentiments

Stock Price